Epinephrine auto-injectors are used for the treatment of anaphylaxis that used in individuals affected by cardiac arrest, allergy and asthma. Epinephrine could be a colourless clear sterile solution also known as adrenaline. These auto injectors are the basic treatment for treating anaphylaxis that enables non-medical people to treat the disorder effectively. Delayed administration could increase the risk of death. The drug enables to reverse symptoms of an allergic reaction by opening airways, accelerating the heart rate and maintaining the blood pressure. They’re available as pre-filled auto injecting devices that contain the drug to be injected underneath the skin or into the muscle on the outer side of the thigh. Currently, there are two epinephrine auto-injectors out there Anapen and Epipen and that they are classified as S3 drugs that permit them to be bought from a pharmacy without a prescription.
How Big is The Global Epinephrine auto-injectors Market?
The Epinephrine auto-injectors Market is expected to be around US$ 3.25 Billion by 2028 at a CAGR of 7% in the given forecast period.
The major driving factors of Epinephrine auto-injectors Market are as follows:
The major challenges of Epinephrine auto-injectors Market are as follows:
The Epinephrine auto-injectors Market has been segmented as below:
By Dosage:
By Age:
By End User:
By Regional Analysis:
The Epinephrine auto-injectors Market is segmented on the lines of its dosage, age, end user and regional. Based on dosage it covers 0.15mg epinephrine auto injector, 0.3mg epinephrine auto injector and 0.5mg epinephrine auto injector. Based on age it covers < 6 Years, 6-12 Years and > 12 Years. Based on end user it covers Hospitals, Clinics and Individuals. The Epinephrine auto-injectors Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Epinephrine auto-injectors Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Epinephrine auto-injectors Market
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Report Scope:
The scope of the report includes a detailed study of Epinephrine auto-injectors Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report Amedra Pharmaceuticals LLC, Mylan Inc, ALK Abello, Sanofi SA, Lincoln Medical Ltd, Itelliject Inc, Adamis Pharmaceuticals Corp, Hospira Inc, Teva Pharmaceuticals Ltd and Antares Pharma Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Epinephrine auto-injectors Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Epinephrine auto-injectors Market.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
X-ray Fluorescence Spectrometers Market
Asia-Pacific Home Cold Light Tooth Whitening Apparatus Market
1. Introduction
1.1 Key Findings
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Data
2.2 Market Size Estimation and Data Triangulation
2.3 Research Assumptions
3. Summary with Insights
4. Market Overview
4.1 Introduction
4.2 Drivers
4.2.1 Increasing prevalence of allergies
4.2.2 Technological advances
4.3 Challenges
4.3.1 Product recalls and regulatory issues
4.3.2 High cost
4.4 Industry Trends
4.5 Porter’s Five Forces Analysis
5. Epinephrine auto-injectors Market Analysis, By Dosage
5.1 0.15mg epinephrine auto injector
5.2 0.3mg epinephrine auto injector
5.3 0.5mg epinephrine auto injector
6. Epinephrine auto-injectors Market Analysis, By Age
6.1 < 6 Years
6.2 6-12 Years
6.3 > 12 Years
7. Epinephrine auto-injectors Market Analysis, By End User
7.1 Hospitals
7.2 Clinics
7.3 Individuals
8. Epinephrine auto-injectors Market Analysis, By Region
8.1 North America
8.2 Europe
8.3 Asia-Pacific
8.4 Rest of the World
9. Competitive Overview
9.1 Introduction
9.2 New Product Launches
9.3 Acquisitions
9.4 Agreements, Partnerships, And Collaborations
9.5 Expansions
10. Company Profiles
10.1 Antares Pharma Inc.
10.2 Sanofi SA
10.3 Lincoln Medical Ltd
10.4 Itelliject Inc
10.5 Adamis Pharmaceuticals Corp
10.6 Amedra Pharmaceuticals LLC
10.7 Mylan Inc
10.8 ALK Abello
10.9 Hospira Inc
10.10 Teva Pharmaceuticals Ltd
The Epinephrine auto-injectors Market has been segmented as below:
By Dosage:
By Age:
By End User:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
